Michael J. Murphy
Table of Contents:1. Introduction to Diagnostic and Prognostic Biomarkers and Therapeutic Targets in MelanomaMichael J. Murphy2. Diagnostic and Prognostic Biomarkers in Melanoma: Current State of Play Jochen Utikal, Jürgen C. Becker, and Selma Ugurel3. Molecular Pathogenesis of Melanoma: Established and Novel PathwaysPaolo Antonio Ascierto, Maria Libera Ascierto, Mariaelena Capone, Zendee Elaba, Michael J. Murphy, and Giuseppe Palmieri4. Staging of MelanomaZendee Elaba, Michael J. Murphy, Philip Kerr, and Jane M. Grant-Kels 5. Clinical and Histopathological Parameters in MelanomaCheryl Bilinski, Avery LaChance, and Michael J. Murphy6. Genetic/Epigenetic Biomarkers: Distinction of Melanoma from Other Melanocytic NeoplasmsMinoru Takata 7. mRNA Biomarkers in MelanomaGiovanna Chiorino and Maria Scatolini8. Epigenetic Biomarkers in MelanomaSuhu Liu, Suping Ren, Paul M. Howell Jr., and Adam I. Riker9. microRNA Biomarkers in MelanomaJim Kozubek, Faseeha Altaf and Soheil S. Dadras10. MicroRNAs as Biomarkers and Therapeutic Targets in MelanomaDaniel W. Mueller, Anja K. Bosserhoff11. Mitochondrial DNA Biomarkers in MelanomaMark L. Steinberg12. Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (A) DiagnosisSteven J. Ohsie, Basil A. Horst, Alister Cochran, and Scott W. Binder13. Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (B) PrognosticationBasil A. Horst, Steven J. Ohsie, Alister Cochran, and Scott W. Binder14. Tissue-Based Protein Biomarkers in Melanoma: Mass Spectrometry-Based StrategiesMichael J. Murphy, Karim Rezaul, and David K. Han15. Serological Biomarkers in MelanomaMel Ziman, Michael Millward, Robert Pearce, and Mark Lee16. Molecular Markers of Lymph Node Disease in MelanomaSandro Pasquali, Augustinus P.T. van der Ploeg, and Simone Mocellin17. Melanoma Cell Propagation: Cancer Stem Cell, Clonal Evolution and Interconversion Models of TumorigenicityQiuzhen Liu, Marianna Sabatino, David F. Stroncek, Ping Jin, Francesco M. Marincola, and Ena Wang 18. Surgical Management of Melanoma: Concept of Field Cancerization and Molecular Evaluation of Tissue MarginsAmanda Phelps and Michael J. Murphy19. Chemotherapy for MelanomaHedwig Stanisz, Thomas Vogt, and Knuth Rass20. Molecular-Targeted Therapy for MelanomaAlessia E. Russo, Ylenia Bevelacqua, Andrea Marconi, Andrea Veronesi, and Massimo Libra21. Anti-Angiogenesis Therapy for MelanomaRoberta Ferraldeschi and Paul Lorigan22. Immunological Biomarkers and Immunotherapy for MelanomaJochen T. Schaefer23. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma: An OverviewAhmad A. Tarhini and John M. Kirkwood